May 27 – Prematics president and chief executive officer, Kevin Hutchinson, has been named an inaugural member of the Board of Managers for TransforMED LLC, a wholly owned subsidiary

Aug. 15 : BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, announced today that it has appointed Dr. Thaddeus Pullano, 53, as Vice President of Quality Assurance.

January 3 – Ambion, Inc., announced that Dr. Jeffrey Williams has been named Executive Vice President and General Manager of Ambion RNA Diagnostics,